| Name | Title | Contact Details |
|---|
We are a developer, manufacturer and marketer of prefabricated, semi-custom and custom orthoses. Orthomerica is known for providing exceptional customer service, quality, innovation and prompt delivery of orthopaedic braces to the orthotics and
Goodroot is a community of companies committed to reinventing healthcare one system at a time. Our mission is to reshape how our current system operates and make healthcare more affordable and more accessible for all. We develop and leverage businesses that not only improve the current state of healthcare delivery, but that also reform or replace the most critical parts of the system that are no longer working. Goodroot offers and sells the full range of products and services of all brands and companies underneath our umbrella to offer the most idealistic approach of capabilities for our clients. With a growing group of brands including RemedyOne, AlignRx, Penstock, Famulus, CoeoRx and ScholarScripts, Goodroot aims to helps everyone from pharmacy management to payment integrity and everyone in between.
At Clinipace, a global, full-service contract research organization (CRO), our approach to clinical research is personal. We deliver a level of collaboration and flexibility not possible in a traditional CRO environment. Our personalized services and solutions, local regulatory expertise and therapeutic leadership are designed to face the most difficult industry challenges across all major therapeutic areas including oncology, gastroenterology, nephrology and urology. We strive to improve the way clinical research is performed and impact the future of health care using the most advanced technology and a CHALLENGE ACCEPTED approach. In April 2021, Clinipace & dMed merged creating a differentiated mid-size CRO with the largest Asia-Pacific presence. We are proud to have such a strong group of global investors focused on improving healthcare outcomes and giving sponsors a better CRO choice. dMed`s 2019 acquisition of Target Health commenced the process of building a Next Generation global CRO for biotech and pharmaceutical companies. Our investors have invested over $230M to build the next great global CRO. dMed`s acquisition of Target Health in 2019 began dMed`s evolution from a local to global CRO. Target Health LLC is owned by dMedClinical Co. Ltd., a privately held company that is majority owned, operated, managed, and controlled by a U.S. citizen and foreign entities located in the People`s Republic of China. Dr. Lingshi Tan, is the aforementioned U.S. citizen currently residing in Shanghai, China. Dr. Tan moved to Shanghai (from New York) to become Pfizer`s VP of Worldwide Development Operations, and Chairman and General Manager of Pfizer (China) Research & Development Co. Dr. Tan founded dMed in 2016 to satisfy the local demand for a high quality, responsive, flexible CRO.
Hillsboro Medical Ctr is a Hillsboro, ND-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
East Tennessee Behavioral Health is a hospital and treatment facility for adolescents and adults struggling with mental health concerns such as anxiety disorders, depression, bipolar disorder, and posttraumatic stress disorder (PTSD).